-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Madrigal Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q4 2024.
- Madrigal Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was -$67M, a 42.8% increase year-over-year.
- Madrigal Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$498M, a 30.8% decline year-over-year.
- Madrigal Pharmaceuticals, Inc. annual Operating Income (Loss) for 2024 was -$498M, a 30.8% decline from 2023.
- Madrigal Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$380M, a 29.6% decline from 2022.
- Madrigal Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$294M, a 21.1% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)